it is my pleasure to update you on the progress of Ian Watson, PhD, of McGill University, who is conducting research supported by you under his MRA Young Investigator Award, Identification of therapeutic strategies to target NF1 mutant melanomas. Dr. Watson and his research team made significant progress in the first ye